Additional file 2 of Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004–2024)
收藏数据链接：
官方服务：
资源简介：
Supplementary Material Table S2: Signal strength for adverse drug events with no less than three counts for cetrorelix as comparators for ganirelix.
创建时间：
2025-04-22
